- Home
- TRIB vs PLUR Comparison
TRIB vs PLUR Comparison
Compare TRIB & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- PLUR
- Stock Information
- Founded
- TRIB 1992
- PLUR 2001
- Country
- TRIB Ireland
- PLUR Israel
- Employees
- TRIB N/A
- PLUR N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRIB Health Care
- PLUR Health Care
- Exchange
- TRIB Nasdaq
- PLUR Nasdaq
- Market Cap
- TRIB 25.5M
- PLUR 24.9M
- IPO Year
- TRIB N/A
- PLUR N/A
- Fundamental
- Price
- TRIB $0.77
- PLUR $4.33
- Analyst Decision
- TRIB
- PLUR
- Analyst Count
- TRIB 0
- PLUR 0
- Target Price
- TRIB N/A
- PLUR N/A
- AVG Volume (30 Days)
- TRIB 6.3M
- PLUR 6.8K
- Earning Date
- TRIB 04-03-2025
- PLUR 02-11-2025
- Dividend Yield
- TRIB N/A
- PLUR N/A
- EPS Growth
- TRIB N/A
- PLUR N/A
- EPS
- TRIB N/A
- PLUR N/A
- Revenue
- TRIB $59,126,000.00
- PLUR $678,000.00
- Revenue This Year
- TRIB $11.63
- PLUR N/A
- Revenue Next Year
- TRIB $10.13
- PLUR N/A
- P/E Ratio
- TRIB N/A
- PLUR N/A
- Revenue Growth
- TRIB N/A
- PLUR 89.92
- 52 Week Low
- TRIB $0.73
- PLUR $4.07
- 52 Week High
- TRIB $3.55
- PLUR $8.48
- Technical
- Relative Strength Index (RSI)
- TRIB 43.29
- PLUR 45.34
- Support Level
- TRIB $0.73
- PLUR $4.45
- Resistance Level
- TRIB $0.82
- PLUR $4.78
- Average True Range (ATR)
- TRIB 0.06
- PLUR 0.20
- MACD
- TRIB -0.01
- PLUR 0.01
- Stochastic Oscillator
- TRIB 14.77
- PLUR 17.86
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.